These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35884982)

  • 1. Patient-Derived Lung Tumoroids-An Emerging Technology in Drug Development and Precision Medicine.
    Lê H; Seitlinger J; Lindner V; Olland A; Falcoz PE; Benkirane-Jessel N; Quéméneur E
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.
    Kalla J; Pfneissl J; Mair T; Tran L; Egger G
    Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38806997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of canine mammary tumoroids for translational research.
    Raffo-Romero A; Aboulouard S; Bouchaert E; Rybicka A; Tierny D; Hajjaji N; Fournier I; Salzet M; Duhamel M
    BMC Biol; 2023 Feb; 21(1):23. PubMed ID: 36737789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling.
    Cromwell EF; Sirenko O; Nikolov E; Hammer M; Brock CK; Matossian MD; Alzoubi MS; Collins-Burow BM; Burow ME
    SLAS Discov; 2022 Apr; 27(3):191-200. PubMed ID: 35124274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patient-derived tumor organoids (or tumoroid) as valuable precision medicine tools].
    Perréard M; Florent R; Thorel L; Vincent A; Weiswald LB; Poulain L
    Med Sci (Paris); 2022 Nov; 38(11):888-895. PubMed ID: 36448894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patient-derived tumor organoids (or tumoroid), a growing preclinical model for oncology].
    Thorel L; Florent R; Perréard M; Vincent A; Poulain L; Weiswald LB
    Med Sci (Paris); 2022 Nov; 38(11):880-887. PubMed ID: 36448893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model.
    Ozturk S; Gorgun C; Gokalp S; Vatansever S; Sendemir A
    Biotechnol Bioeng; 2020 Aug; 117(8):2527-2539. PubMed ID: 32391924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial tumor matrices and bioengineered tools for tumoroid generation.
    Liu YC; Chen P; Chang R; Liu X; Jhang JW; Enkhbat M; Chen S; Wang H; Deng C; Wang PY
    Biofabrication; 2024 Mar; 16(2):. PubMed ID: 38306665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry (IHC) staining of in-vitro cancer cell-generated tumoroids.
    Amereh M; Akbari M
    MethodsX; 2023; 10():102242. PubMed ID: 37346478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
    Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in vitro 3D cultures.
    Mousavi N
    APMIS; 2021 Aug; 129 Suppl 142():1-30. PubMed ID: 34399444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors.
    April-Monn SL; Wiedmer T; Skowronska M; Maire R; Schiavo Lena M; Trippel M; Di Domenico A; Muffatti F; Andreasi V; Capurso G; Doglioni C; Kim-Fuchs C; Gloor B; Zatelli MC; Partelli S; Falconi M; Perren A; Marinoni I
    Neuroendocrinology; 2021; 111(3):273-287. PubMed ID: 32241015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin blunted the angiogenic activity in 3D colon cancer tumoroids by the reduction of endocan.
    Narmi MT; Shoja HM; Haiaty S; Mahdipour M; Rahbarghazi R
    Cancer Cell Int; 2023 Jun; 23(1):118. PubMed ID: 37337165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients Lung Derived Tumoroids (PLDTs) to model therapeutic response.
    Delom F; Begiristain I; Grenier T; Begueret H; Soulet F; Siegfried G; Khatib AM; Robert J; Fessart D
    Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118808. PubMed ID: 32781095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive three-dimensional silk composite in vitro tumoroid model for high throughput screening of anticancer drugs.
    Arora D; Bhunia BK; Janani G; Mandal BB
    J Colloid Interface Sci; 2021 May; 589():438-452. PubMed ID: 33485251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion Analysis.
    Liu YC; Ansaryan S; Tan J; Broguiere N; Lorenzo-Martín LF; Homicsko K; Coukos G; Lütolf MP; Altug H
    Adv Sci (Weinh); 2024 Jun; ():e2401539. PubMed ID: 38924371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biohybrid Hydrogels for Tumoroid Culture.
    Castellote-Borrell M; Merlina F; Rodríguez AR; Guasch J
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300118. PubMed ID: 37505458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
    Xu H; Jiao D; Liu A; Wu K
    J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy.
    Yao L; Zao XL; Pan XF; Zhang HG; Wang FJ; Qiao PF
    J Chemother; 2023 Apr; 35(2):104-116. PubMed ID: 35285783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.